Gotistobart Long Term Extension (LTE) Study

NCT07659379 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Gotistobart

Sponsor

OncoC4, Inc.